MedTrace Logo

Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product

NCT02615561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2017-09-15

No results posted yet for this study

Summary

1. Curing mild atopic dermatis in children with a commerical medical device (Bepanthen Itch Relief Cream).
2. Maintaining healthy skin by using a new cosmetic Bepanthen product or a commercially available cosmetic product

Conditions

  • Dermatitis, Atopic

Interventions

DEVICE

Bepanthen Itch Relief Cream: Phoenix 2 (Bepanthen Sensiderm, BAY207543)

2-3 times daily using multiples of Finger Tip Units (FTUs) depending on size of the area of the flares

OTHER

New cosmetic Bepanthen product: Pumpkin (BAY207543)

Twice daily on the whole body; about 10 FTUs (i.e. 5g) per application depending on age of subject

OTHER

Stelatopia (cosmetic comparator)

Twice daily on the whole body; about 10 FTUs (i.e. 5g) per application depending on age of subject

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-15
Primary Completion
2016-09-07
Completion
2016-09-07

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02615561 on ClinicalTrials.gov